Search research articles
Contact Us
Filters
Showing results (1221-1230 of 1,356) with videos related to
Page
of 136
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
Diagnostic Performance of [<sup>18</sup>F]PSMA-1007 PET/CT on Proven PSMA-Positive Hepatocellular Carcinoma: A Prospective Clinical Study
Kerstin Michalski, Florian P Reiter, Aleksander Kosmala, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 21, 2013
Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality
K Cupisti, N Lehwald, M Anlauf, et al.
Toxicology and Applied Pharmacology
|
May 18, 2021
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS<sup>G12C</sup>, are associated with renal toxicity in the Sprague Dawley rat
Jonathan A Werner, Rhian Davies, Jan Wahlstrom, et al.
HNO
|
April 3, 2016
[Multicenter trial for sudden hearing loss therapy - planning and concept]
S K Plontke, M Girndt, C Meisner, et al.
Journal of Neuroimmunology
|
December 6, 2021
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer
Michelle C Janelsins, Lianlian Lei, Colleen Netherby-Winslow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Scientific Reports
|
September 14, 2017
Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma
Thomas A Werner, Levent Dizdar, Inga Nolten, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 1, 2025
Refining the clinical utility of [<sup>177</sup>Lu]Lu/[<sup>225</sup>Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Endocrine
|
May 4, 2016
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography
Rudolf A Werner, Matthias Kroiss, Masatoyo Nakajo, et al.
Page
of 136
Search research articles
Search
Showing results (1221-1230 of 1,356) with videos related to
Sort By:
Page
of 136
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
Diagnostic Performance of [<sup>18</sup>F]PSMA-1007 PET/CT on Proven PSMA-Positive Hepatocellular Carcinoma: A Prospective Clinical Study
Kerstin Michalski, Florian P Reiter, Aleksander Kosmala, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 21, 2013
Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality
K Cupisti, N Lehwald, M Anlauf, et al.
Toxicology and Applied Pharmacology
|
May 18, 2021
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS<sup>G12C</sup>, are associated with renal toxicity in the Sprague Dawley rat
Jonathan A Werner, Rhian Davies, Jan Wahlstrom, et al.
HNO
|
April 3, 2016
[Multicenter trial for sudden hearing loss therapy - planning and concept]
S K Plontke, M Girndt, C Meisner, et al.
Journal of Neuroimmunology
|
December 6, 2021
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer
Michelle C Janelsins, Lianlian Lei, Colleen Netherby-Winslow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Scientific Reports
|
September 14, 2017
Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma
Thomas A Werner, Levent Dizdar, Inga Nolten, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 1, 2025
Refining the clinical utility of [<sup>177</sup>Lu]Lu/[<sup>225</sup>Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Endocrine
|
May 4, 2016
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography
Rudolf A Werner, Matthias Kroiss, Masatoyo Nakajo, et al.
Page
of 136